Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Adler

Showing results (121-130 of 203) with videos related to

Pageof 21
Sort By:
The Lancet. Neurology|October 7, 2014
Alemtuzumab for relapsing-remitting multiple sclerosisRichard A Diaz, Sally Doss, Martyn J Burke, et al.
Diabetes Care|June 7, 2008
Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adultsAmanda I Adler, Brian S F Shine, Parinya Chamnan, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 8, 2011
Smoking and other factors associated with short-term partial remission of Type 1 diabetes in adultsS Pilacinski, A I Adler, D A Zozulinska-Ziolkiewicz, et al.
Diabetes|May 30, 2006
Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74Ravi Retnakaran, Carole A Cull, Kerensa I Thorne, et al.
Diabetes Care|November 18, 2009
Diabetes as a determinant of mortality in cystic fibrosisParinya Chamnan, Brian S F Shine, Charles S Haworth, et al.
Diabetes Care|June 24, 2021
Increased Risk of Incident Heart Failure and Death Is Associated With Insulin Resistance in People With Newly Diagnosed Type 2 Diabetes: UKPDS 89Malgorzata Wamil, Ruth L Coleman, Amanda I Adler, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1989
Ranking risk factors for perinatal mortality. Analysis of a nation-wide studyA Samueloff, S Mor-Yosef, D S Seidman, et al.
Diabetes, Obesity & Metabolism|November 12, 2025
Estimating the risk of cardiovascular outcomes and all-cause mortality in individuals with type 2 diabetes: Validation of the UKPDS outcomes model using TECOS and EXSCEL dataRuth L Coleman, Amanda I Adler, Philip M Clarke, et al.
American Heart Journal|October 28, 1999
Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom prospective diabetes study (UKPDS 47)A I Adler, H A Neil, S E Manley, et al.
Diabetes Care|November 15, 2012
A simple risk stratification for time to development of sight-threatening diabetic retinopathyIrene M Stratton, Stephen J Aldington, David J Taylor, et al.
Pageof 21

Showing results (121-130 of 203) with videos related to

Sort By:
Pageof 21
The Lancet. Neurology|October 7, 2014
Alemtuzumab for relapsing-remitting multiple sclerosisRichard A Diaz, Sally Doss, Martyn J Burke, et al.
Diabetes Care|June 7, 2008
Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adultsAmanda I Adler, Brian S F Shine, Parinya Chamnan, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 8, 2011
Smoking and other factors associated with short-term partial remission of Type 1 diabetes in adultsS Pilacinski, A I Adler, D A Zozulinska-Ziolkiewicz, et al.
Diabetes|May 30, 2006
Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74Ravi Retnakaran, Carole A Cull, Kerensa I Thorne, et al.
Diabetes Care|November 18, 2009
Diabetes as a determinant of mortality in cystic fibrosisParinya Chamnan, Brian S F Shine, Charles S Haworth, et al.
Diabetes Care|June 24, 2021
Increased Risk of Incident Heart Failure and Death Is Associated With Insulin Resistance in People With Newly Diagnosed Type 2 Diabetes: UKPDS 89Malgorzata Wamil, Ruth L Coleman, Amanda I Adler, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1989
Ranking risk factors for perinatal mortality. Analysis of a nation-wide studyA Samueloff, S Mor-Yosef, D S Seidman, et al.
Diabetes, Obesity & Metabolism|November 12, 2025
Estimating the risk of cardiovascular outcomes and all-cause mortality in individuals with type 2 diabetes: Validation of the UKPDS outcomes model using TECOS and EXSCEL dataRuth L Coleman, Amanda I Adler, Philip M Clarke, et al.
American Heart Journal|October 28, 1999
Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom prospective diabetes study (UKPDS 47)A I Adler, H A Neil, S E Manley, et al.
Diabetes Care|November 15, 2012
A simple risk stratification for time to development of sight-threatening diabetic retinopathyIrene M Stratton, Stephen J Aldington, David J Taylor, et al.
Pageof 21